Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?

Download
Full text for this resource is not available from the Research Repository.
Export

Cornall, Lauren, Mathai, Michael ORCID: 0000-0001-8783-2122, Hryciw, Deanne H ORCID: 0000-0003-1697-8890 and McAinch, Andrew ORCID: 0000-0002-8762-4865 (2013) Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases? Expert Opinion on Investigational Drugs, 22 (4). pp. 487-498. ISSN 1354-3784 (print) 1744-7658 (online)

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/21973
DOI 10.1517/13543784.2013.775245
Subjects Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
Historical > FOR Classification > 1101 Medical Biochemistry and Metabolomics
Historical > FOR Classification > 1103 Clinical Sciences
Keywords GPR119, insulin, type 2 diabetes mellitus, metabolic disease, drug therapy, skeletal muscle, metabolism
Citations in Scopus 19 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login

CORE (COnnecting REpositories)